Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.34 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | CCR9 | P51686 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14270403 | 0.88 | CYP2C19 (0.43) | CYP2C19CYP1A2CASP3KDM4EALDH1A1 | |
| SCHEMBL14294443 | 0.88 | CYP2C19 (0.42) | CYP2C19CYP1A2CASP3KDM4EALDH1A1 | |
| SCHEMBL14573889 | 0.86 | CCR9 (0.34) | KDM4EALDH1A1GLO1RXFP1MEN1 | |
| SCHEMBL4909841 | 0.85 | PTGER4 (0.34) | CYP2C19KDM4EALDH1A1CYP3A4CYP2D6 | |
| SCHEMBL4142536 | 0.85 | CYP1A2 (0.44) | CYP2C19CYP1A2CASP3KDM4EALDH1A1 | |
| SCHEMBL4914381 | 0.84 | CYP2C19 (0.39) | CYP2C19CYP1A2CASP3KDM4EALDH1A1 | |
| SCHEMBL4650953 | 0.84 | CYP2C19 (0.39) | CYP2C19CYP1A2CASP3KDM4EALDH1A1 | |
| SCHEMBL4163236 | 0.84 | CYP1A2 (0.43) | CYP2C19CYP1A2CASP3KDM4EALDH1A1 | |
| SCHEMBL4652233 | 0.84 | CYP2C19 (0.43) | CYP2C19CYP1A2CASP3KDM4EALDH1A1 | |
| SCHEMBL14573827 | 0.84 | KDM4E (0.35) | CYP2C19CYP1A2KDM4EALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8008287-B2 | Use treating HIV and AIDS; tricyclic compounds such as those based on 5-sulfonamido-9-hydroxy-6,8-dihydrdo-7H-pyrrolo[3,4-g]quinoline-8-one | GILEAD SCIENCES, INC. (US) | 2011-08-30 | — | — | US | disclosed |
| US-20090306054-A1 | INTEGRASE INHIBITORS | GILEAD SCIENCES ,INC. (US) | 2009-12-10 | — | — | US | disclosed |
| US-20080058315-A1 | Integrase inhibitors | GILEAD SCIENCES, INC. | 2008-03-06 | — | — | US | disclosed |
| US-20080039487-A1 | Processes and intermediates useful for preparing integrase inhibitor compounds | GILEAD SCIENCES, LLC | 2008-02-14 | — | — | US | disclosed |
| US-20080039487-A1 | Processes and intermediates useful for preparing integrase inhibitor compounds | GILEAD SCIENCES, LLC | 2008-02-14 | — | — | US | disclosed |
| US-20070072831-A1 | Integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072831-A1 | Integrase inhibitor compounds | TYMP, CDKN1A, PAICS | CYP2C19 1140/4885CYP1A2 1685/4885CASP3 1295/4885 |
| US-20080039487-A1 | Processes and intermediates useful for preparing integrase inhibitor compounds | TYMP, DUT, SAMHD1 | CYP2C19 349/4885CYP1A2 686/4885CASP3 3791/4885 |
| US-20080058315-A1 | Integrase inhibitors | TYMP, DNTT, PAICS | CYP2C19 1229/4885CYP1A2 1583/4885CASP3 1320/4885 |
| US-20090306054-A1 | INTEGRASE INHIBITORS | TYMP, POLR2E, CCNI | CYP2C19 357/4885CYP1A2 757/4885CASP3 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.